Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Albert CM Ong"'
Publikováno v:
BMJ Open, Vol 10, Iss 1 (2020)
Objectives A number of randomised control trials (RCTs) investigating the effects of long-acting somatostatin analogues in autosomal dominant polycystic kidney disease (ADPKD) and polycystic liver disease (PLD) have been recently reported. We sought
Externí odkaz:
https://doaj.org/article/6420be174d4746d3a7d8499d05c33ac8
Publikováno v:
Advances in Kidney Disease and Health. 30:294-302
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f82f3a59608ba2470a1f6cd22eb28688
https://doi.org/10.1053/j.akdh.2023.01.002
https://doi.org/10.1053/j.akdh.2023.01.002
Autor:
Ronald T, Gansevoort, Ali, Hariri, Pascal, Minini, Curie, Ahn, Arlene B, Chapman, Shigeo, Horie, Bertrand, Knebelmann, Michal, Mrug, Albert Cm, Ong, York Pc, Pei, Vicente E, Torres, Vijay, Modur, Igor, Antonshchuk, Ronald D, Perrone
Publikováno v:
American Journal of Kidney Diseases, 81(5), 517-527.e1. W B SAUNDERS CO-ELSEVIER INC
Rationale & Objective: Autosomal dominant polycystic kidney disease (ADPKD) is characterized by the formation of multiple kidney cysts that leads to growth in total kidney volume (TKV) and progression to kidney failure. Venglustat is a glucosylcerami
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::124719c907294fe39ba73b86da5cc421
https://research.rug.nl/en/publications/2524f3fb-67b7-4b6a-84d7-08d0fa5f43ad
https://research.rug.nl/en/publications/2524f3fb-67b7-4b6a-84d7-08d0fa5f43ad
